Patient characteristics for AML samples
Sample no. . | Age, y . | FAB . | WBC count . | Cytogenetics . | PB/BM . |
---|---|---|---|---|---|
1 | 41 | M1 | 110 170 | Normal | PB |
2 | 39 | M4 | 67 530 | Normal | PB |
3 | 73 | M5 | 139 852 | Normal | PB |
4 | 60 | M0 | 16 130 | Normal | BM |
5 | 69 | M1 | 19 120 | Normal | BM |
6 | 61 | M2 | 24 700 | t(2; 12) | BM |
7 | 61 | MDS/AML | 8 440 | -y | BM |
8 | 50 | M2 | 107 530 | Normal | PB |
Sample no. . | Age, y . | FAB . | WBC count . | Cytogenetics . | PB/BM . |
---|---|---|---|---|---|
1 | 41 | M1 | 110 170 | Normal | PB |
2 | 39 | M4 | 67 530 | Normal | PB |
3 | 73 | M5 | 139 852 | Normal | PB |
4 | 60 | M0 | 16 130 | Normal | BM |
5 | 69 | M1 | 19 120 | Normal | BM |
6 | 61 | M2 | 24 700 | t(2; 12) | BM |
7 | 61 | MDS/AML | 8 440 | -y | BM |
8 | 50 | M2 | 107 530 | Normal | PB |
FAB indicates French-American-British classification; PB, peripheral blood; BM, bone marrow; MDS, myelodysplastic syndrome.